Cell Isolation Industry Trends Growth Future Demand Analysis and Forecast by 2028

Cell Isolation Market in terms of revenue was estimated to be worth $4.4 billion in 2023 and is poised to reach $8.2 billion by 2028, growing at a CAGR of 13.4% from 2023 to 2028 according to a new report by MarketsandMarkets™. Factors such as rising cell-based research and increasing focus on personalized medicine are driving the growth of this market. However, high cost and safety, ethical issues, are the major factors restraining the growth of this market.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=103931479&utm_source=OPenpr&utm_campaign=Paid&utm_content=Referral

Browse in-depth TOC on "Cell Isolation Market"
412 - Tables
46 - Figures
307 - Pages

The consumables segment accounted for the largest share of the product segment in the cell isolation market in 2022.

Based on product, the cell isolation market is broadly segmented into consumables, and instruments. In 2022, consumables accounted for the largest share of the cell isolation market for product. This segment's large share can be attributed to factors such as the wide usage of reagents during cell isolation and continuous introduction of advanced consumables for cell isolation. Consumables can be used for a wide range of applications and cell types, making them a versatile choice for researchers. Some consumables, such as antibody-based cell isolation kits, are non-destructive and can isolate cells without damaging them, which is important for downstream applications. Consumables can be used to isolate large numbers of cells, which is important for applications such as cell therapy and drug discovery where large quantities of cells are needed.

The human cells segment accounted for the largest share of the cell type segment in the cell isolation market in 2022.

Based on cell type, the cell isolation market is categorized into two segments-human cells and animal cells. In 2022, human cells segment accounted for the largest share of cell isolation market. Factors such as the increasing investments by public and private organizations for research on human cells are projecting the segmental growth. The use of human cells for research is regulated by various agencies, such as the FDA and the NIH. Therefore, using human cells that have been obtained from reputable sources can ensure regulatory compliance. Human cells are directly relevant to clinical applications such as regenerative medicine, tissue engineering, and cell-based therapies. This makes human cell isolation an essential part of medical research. Human cells are diverse, which allows for the study of a wide range of diseases and conditions. Human cell isolation allows researchers to isolate specific cell types for further study.

Asia Pacific is likely to grow at double digit growth rate during the forecast period.

The Asia Pacific region is estimated to grow at the highest CAGR in the cell isolation market during the forecast period, this is mainly due to the rising geriatric population and increasing number of hospitals in Asian countries. Moreover, increasing chronic diseases in the countries of this region is likely to boost the market. Also, growing infectious diseases in the region is attracting several foreign investors in the market. Governments in the APAC region are supporting research in various ways, such as funding research institutes and offering tax incentives to biotech and life sciences companies. This has led to an increased demand for cell isolation technologies to support this research.

Inquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=103931479&utm_source=OPenpr&utm_campaign=Paid&utm_content=Referral

Cell Isolation Market Dynamics:

Drivers:

Increasing government funding for cell-based research
Increasing number of patients suffering from cancer and infectious diseases
Technological advancements
Growing focus on personalized medicine

Restraints:

Ethical issues related to embryonic stem cell isolation
High cost of cell-based research

Opportunities:

Emerging markets

Key Market Players:

Some of the prominent players in the cell isolation market are Danaher Corporation (US), Merck KGaA (Germany), Thermo Fisher Scientific, Inc. (US), Becton, Dickinson and Company (US), Terumo Corporation (Japan), Agilent Technologies, Inc. (US), Bio-Rad Laboratories, Inc. (US), Corning Incorporated (US), F. Hoffmann-La Roche Ltd. (Switzerland), Miltenyi Biotec (Germany), STEMCELL Technologies (Canada), Alfa Laval (Sweden), Sartorius AG (Germany), Akadeum Life Sciences (US), Bio-Techne (US), PerkinElmer Inc. (US), Invent Biotechnologies, Inc. (US), Takara Bio, Inc. (Japan), MiCareo Inc. (US), Proteintech Group, Inc. (US), QIAGEN (Germany), Lonza (Switzerland), Promega Corporation (US), PluriSelect Life Science UG (Haftungsbeschränkt) & Co. KG (Germany), and MagBio Genomics (US).

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=103931479&utm_source=OPenpr&utm_campaign=Paid&utm_content=Referral

Recent Developments:

In October 2022, Thermo Fisher Scientific, Inc. launched DynaCellect, a next-generation cell isolation, cell activation, cell depletion instrument.

It also launched the Dynabeads magnetic beads removal instrument to optimize the cell therapy manufacturing process.

In June 2022, Terumo BCT and GenCure collaborated to advance cell and gene therapy manufacturing solutions.

In May 2022, Terumo BCT inaugurated its second manufacturing facility in Colorado.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/cell-isolation-market.asp
Visit Our Website: https://www.marketsandmarkets.com/
Content Source: https://www.marketsandmarkets.com/PressReleases/cell-isolation.asp

About MarketsandMarkets™:

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

This release was published on openPR.